fosamprenavir has been researched along with atazanavir in 3 studies
| Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (atazanavir) | Trials (atazanavir) | Recent Studies (post-2010) (atazanavir) |
|---|---|---|---|---|---|
| 174 | 55 | 37 | 75 | 1 | 37 |
| Protein | Taxonomy | fosamprenavir (IC50) | atazanavir (IC50) |
|---|---|---|---|
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | 5.2 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 0.375 | |
| UDP-glucuronosyltransferase 1A1 | Rattus norvegicus (Norway rat) | 4.2 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.026 | |
| Protease | Human immunodeficiency virus 1 | 0.004 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 0.4 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.4 | |
| Protease | Human immunodeficiency virus 1 | 0.0017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babusis, D; Bhoopathy, S; Hidalgo, IJ; Phan, TK; Ray, AS; Rhodes, GR; Robinson, KL; Strab, R; Tong, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| A M Subbaiah, M; Annadurai, M; Arla, R; Bhutani, P; Desai, SD; Desikan, S; Jenkins, SM; Kadow, JF; Krystal, MR; Mandlekar, S; Meanwell, NA; Padmanabhan, S; Ramar, T; Singh, S; Sinha, J; Sinha, S; Sridhar, S; Subramani, L; Subramanian, M; Thakur, M | 1 |
1 review(s) available for fosamprenavir and atazanavir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for fosamprenavir and atazanavir
| Article | Year |
|---|---|
Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.
Topics: Adenine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Epithelium; HIV Protease Inhibitors; Humans; Hydrolysis; Indicators and Reagents; Intestinal Absorption; Mass Spectrometry; Organophosphonates; Subcellular Fractions; Tenofovir | 2007 |
Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
Topics: Administration, Oral; Amino Acids; Animals; Area Under Curve; Atazanavir Sulfate; Biological Availability; Drug Design; Esters; HIV Protease Inhibitors; Humans; Phosphates; Prodrugs | 2019 |